J. Bruynseels

487 total citations
18 papers, 405 citations indexed

About

J. Bruynseels is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J. Bruynseels has authored 18 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in J. Bruynseels's work include Estrogen and related hormone effects (11 papers), Prostate Cancer Treatment and Research (5 papers) and Hormonal and reproductive studies (3 papers). J. Bruynseels is often cited by papers focused on Estrogen and related hormone effects (11 papers), Prostate Cancer Treatment and Research (5 papers) and Hormonal and reproductive studies (3 papers). J. Bruynseels collaborates with scholars based in Belgium, Netherlands and Canada. J. Bruynseels's co-authors include R. De Coster, Willem K. Amery, Walter Wouters, Peter De Porre, L. Denis, F.M.J. Debruyne, Eric Snoeck, Paul E. Goss, R. Van Ginckel and A. Van Peer and has published in prestigious journals such as European Journal of Cancer, Urology and Breast Cancer Research and Treatment.

In The Last Decade

J. Bruynseels

18 papers receiving 386 citations

Peers

J. Bruynseels
R. Van Ginckel Belgium
J.C. Faye France
Salvatore Mancuso Italy
Lucia M. Polito Italy
John Patterson United Kingdom
Munawar Iqbal United Kingdom
Jean-Claude Philippe France
N. Devleeschouwer Belgium
V. Wiebe United States
P.A. Beranek United Kingdom
R. Van Ginckel Belgium
J. Bruynseels
Citations per year, relative to J. Bruynseels J. Bruynseels (= 1×) peers R. Van Ginckel

Countries citing papers authored by J. Bruynseels

Since Specialization
Citations

This map shows the geographic impact of J. Bruynseels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bruynseels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bruynseels more than expected).

Fields of papers citing papers by J. Bruynseels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bruynseels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bruynseels. The network helps show where J. Bruynseels may publish in the future.

Co-authorship network of co-authors of J. Bruynseels

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bruynseels. A scholar is included among the top collaborators of J. Bruynseels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bruynseels. J. Bruynseels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kumar, Prem, et al.. (2002). Effect of Adenosine on CO2 Chemosensitivity. Advances in experimental medicine and biology. 475. 405–410. 2 indexed citations
2.
Goss, Paul E., Amit M. Oza, Jean‐Marc Nabholtz, et al.. (2000). Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer. Breast Cancer Research and Treatment. 59(1). 55–68. 18 indexed citations
3.
Goss, Paul E., David Walde, R. De Coster, Christine Langenaeken, & J. Bruynseels. (1999). Rivizor – A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure. Oncology. 56(2). 114–121. 6 indexed citations
4.
Debruyne, F., Robin Murray, Yves Fradet, et al.. (1998). Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Urology. 52(1). 72–81. 42 indexed citations
5.
6.
Denis, L., F.M.J. Debruyne, Peter De Porre, & J. Bruynseels. (1998). Early clinical experience with liarozole (Liazal ™ ) in patients with progressive prostate cancer. European Journal of Cancer. 34(4). 469–475. 24 indexed citations
7.
Bruynseels, J., et al.. (1997). Liarozole (R75251) in hormone-resistant prostate cancer patients. The Prostate. 33(1). 26–31. 15 indexed citations
8.
Bruynseels, J., et al.. (1997). Liarozole (R75251) in hormone‐resistant prostate cancer patients. The Prostate. 33(1). 26–31. 1 indexed citations
9.
Coster, R. De, Walter Wouters, & J. Bruynseels. (1996). P450-dependent enzymes as targets for prostate cancer therapy. The Journal of Steroid Biochemistry and Molecular Biology. 56(1-6). 133–143. 76 indexed citations
10.
Goss, Paul E., Roy M. Clark, U Ambus, et al.. (1995). Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.. PubMed. 1(3). 287–94. 32 indexed citations
11.
Coster, R. De, et al.. (1994). Liarozole Fumarate < Rec INNM; BANM >. Drugs of the Future. 19(6). 552–552. 3 indexed citations
12.
Belle, S.J.P. Van, et al.. (1994). Phase I trial of erbulozole (R55104).. PubMed. 13(6B). 2389–91. 4 indexed citations
13.
14.
Borms, Marleen, et al.. (1993). Vorozole-racemate (R 76713): A specific non-steroidal aromatase inhibitor. Pilot study advanced postmenopausal breast cancer. European Journal of Cancer. 29. S84–S84. 3 indexed citations
15.
Denis, L., F.M.J. Debruyne, Peter De Porre, & J. Bruynseels. (1993). Liarozole-hydrochloride (R 75251), a novel treatment in hormone-resistant prostatic cancer: Response on PSA. European Journal of Cancer. 29. S236–S236. 1 indexed citations
16.
Amery, Willem K. & J. Bruynseels. (1992). Levamisole, the story and the lessons. International Journal of Immunopharmacology. 14(3). 481–486. 71 indexed citations
17.
Bruynseels, J., R. De Coster, P. Van Rooy, et al.. (1990). R 75251, a new inhibitor of steroid biosynthesis. The Prostate. 16(4). 345–357. 50 indexed citations
18.
Coster, R. De, Walter Wouters, C R Bowden, et al.. (1990). New non-steroidal aromatase inhibitors: Focus on R76713. The Journal of Steroid Biochemistry and Molecular Biology. 37(3). 335–341. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Van Ginckel Breakdown of academic impact, for papers by J.C. Faye Breakdown of academic impact, for papers by Salvatore Mancuso Breakdown of academic impact, for papers by Lucia M. Polito Breakdown of academic impact, for papers by John Patterson Breakdown of academic impact, for papers by Munawar Iqbal Breakdown of academic impact, for papers by Jean-Claude Philippe Breakdown of academic impact, for papers by N. Devleeschouwer Breakdown of academic impact, for papers by V. Wiebe Breakdown of academic impact, for papers by P.A. Beranek
Rankless by CCL
2026